(Q37847138)

24 August 2017

1 reference

title

Current management of primary sclerosing cholangitis in pediatric patients (English)

1 reference

24 August 2017

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

Samar H Ibrahim

1

1 reference

24 August 2017

Keith D Lindor

series ordinal

2

1 reference

24 August 2017

publication date

1 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

87-95

1 reference

https://scigraph.springernature.com/pub.10.2165/11586500-000000000-00000

24 August 2017

exact match

0 references

cites work

Primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Sclerosing cholangitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Primary sclerosing cholangitis in children: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

A retrospective single-center review of primary sclerosing cholangitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Autoantibodies in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Primary sclerosing cholangitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Liver involvement in the histiocytic disorders of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Pediatric MR cholangiopancreatography: principles, technique, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Primary sclerosing cholangitis: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

The medical management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Use of ursodeoxycholic acid in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Pirfenidone in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Use of rifampin for severe pruritus in children with chronic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Treatment of cholestatic pruritus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Pathogenesis and treatment of pruritus in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Review article: pruritus in cholestatic and other liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Primary sclerosing cholangitis: surgical options, prognostic variables and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586500-000000000-00000

Induction of hepatic microsomal enzymes after brief administration of rifampicin in man

21 January 2018

1 reference

12 December 2020

Rational approach to pharmacologic reduction of cholesterol levels in children

1 reference

12 December 2020

A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Tacrolimus for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis: findings on cholangiography and pancreatography

1 reference

12 December 2020

Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.

1 reference

12 December 2020

Primary sclerosing cholangitis in children: a histologic follow-up study

1 reference

12 December 2020

Surgical aspects of sclerosing cholangitis. Results in 178 patients

1 reference

12 December 2020

Liver disease in children with primary immunodeficiencies

1 reference

12 December 2020

Endoscopic management of biliary tract strictures in primary sclerosing cholangitis

1 reference

12 December 2020

The Effects of Phenobarbital on Bile Salts and Bilirubin in Patients with Intrahepatic and Extrahepatic Cholestasis

1 reference

12 December 2020

Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report

1 reference

12 December 2020

Primary sclerosing cholangitis in childhood

1 reference

12 December 2020

Stimulation of bile acid 6 alpha-hydroxylation by rifampin

1 reference

12 December 2020

Bile acids for primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis in a child treated by nonsurgical balloon dilatation and stenting

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

12 December 2020

Recurrence of primary sclerosing cholangitis following liver transplantation

1 reference

12 December 2020

Risk factors for recurrence of primary sclerosing cholangitis of liver allograft

1 reference

12 December 2020

Pain as a complication of use of opiate antagonists for symptom control in cholestasis

1 reference

12 December 2020

Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis

1 reference

12 December 2020

Ursodeoxycholic acid therapy in children with cholestatic liver disease

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

Endoscopic therapy of sclerosing cholangitis

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children

1 reference

12 December 2020

Propranolol therapy for portal hypertension in children

1 reference

12 December 2020

Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis

1 reference

12 December 2020

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

12 December 2020

Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation

1 reference

12 December 2020

Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study

1 reference

12 December 2020

Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults

1 reference

12 December 2020

Glucocorticosteroids for primary sclerosing cholangitis

1 reference

12 December 2020

10.2165/11586500-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1052222394

0 references

1 reference